Johnson & Johnson News

Johnson & Johnson is a large and diverse company, so staying up-to-date with developments, company performance, and their plans for the future is not easy. That's why Wiser created the Johnson & Johnson news digest. It is delivered once a day and contains the key articles from around the web in order to keep you informed. Johnson & Johnson is primarily involved in the health sector. Its interests are spread across 275 different companies in 60 countries. It was founded in 1886 and its headquarters is in New Jersey. Worldwide it employs about 128,000 people and its main consumer brands include Band-Aid, Johnson's baby products and Neutrogena. It also has a medical devices and diagnostics sector, and a pharmaceuticals sector. Challenges exist in the later, particularly regarding the competition from generic versions of some of its drugs. Its research and development pipeline is also watched with interest, as is its movements in terms of expansion - further acquisitions, particularly in the medical devices field, are expected. Make sure you do not miss any Johnson & Johnson news, analysis or information by registering for the free Wiser daily email.

Recent Johnson & Johnson News Coverage
 
Your Weekly Recommendations Monday, February 20, 2017
 
Recommended for you
Johnson & Johnson's Ethicon buys Torax Medical
Seeking Alpha • Seeking Alpha
Why You Should Surround Yourself With Great People
Fortune Magazine • Clifton Leaf
Johnson & Johnson Is Not Cheap, And It Never Will Be
Seeking Alpha • Healthy Wealth Coach
Integra LifeSciences (IART) Acquires Johnson & Johnson's (JNJ) Codman Neurosurgery Business - Slideshow
Seeking Alpha
Johnson & Johnson: Strong And Steady Dividend Champ
Seeking Alpha • John Dicecco
Johnson & Johnson: What Will The 55th Dividend Increase Be?
Seeking Alpha • William Stamm
Nurofen maker acquires US baby food and Choco Milk company
The Guardian • Julia Kollewe
Johnson & Johnson To Acquire Actelion For $30 Billion: Is This A Smart Move?
Seeking Alpha • Friedrich Research
Medical device market to reach $428.97B by 2020 — 6 details
Becker's Spine Review • Adam Schrag
Johnson & Johnson: Betting On Growth
Seeking Alpha • Activist Stocks
 
Recommended for You
Johnson & Johnson
Johnson & Johnson's Ethicon buys Torax Medical
Seeking AlphaSeeking Alpha
Johnson & Johnson's (NYSE:JNJ) Ethicon unit acquires privately held St. Paul, MN-based Torax Medical for an undisclosed sum. The transaction should close this quarter. Torax's core technology applies the properties of specialized magnets to restore the barrier function of sphincters. Its lead...
Share
Johnson & Johnson
Why You Should Surround Yourself With Great People
Fortune MagazineClifton Leaf
This essay appears in today's edition of the Fortune Brainstorm Health Daily. Get it delivered straight to your inbox. I’ve spent this morning and yesterday at the Lake Nona Impact Forum in Orlando—listening and taking part in some really thoughtful conversations about...
Share
Actelion Pharmaceuticals, Finance
Johnson & Johnson Is Not Cheap, And It Never Will Be
Seeking AlphaHealthy Wealth Coach
Summary Forward looking P/E is at a historically attractive level for one of the highest-quality companies on earth. Investors can expect 55th consecutive annual dividend increase in April. Johnson & Johnson is a great defensive stock to buy this far into an...
Share
Health Finance, Johnson & Johnson
Integra LifeSciences (IART) Acquires Johnson & Johnson's (JNJ) Codman Neurosurgery Business - Slideshow
Seeking Alpha
The following slide deck was published by Integra LifeSciences Holdings Corporation in conjunction with this event.
Share
Accounting, Finance
Johnson & Johnson: Strong And Steady Dividend Champ
Seeking AlphaJohn Dicecco
Summary Shares are trading at a 27% discount to overall market. Dividend has grown 11.5% annually since 1990. Even a pessimistic future dividend growth model puts stock at $130 by 2020. ChartMasterPro upward target price of $119.00. The market was obviously disappointed...
Share
Actelion Pharmaceuticals, Health Finance
Johnson & Johnson: What Will The 55th Dividend Increase Be?
Seeking AlphaWilliam Stamm
Summary Johnson & Johnson Has increased its dividend for 54 years and presently has a yield of 2.8% which is above average with the last increase declared in April 2016. Johnson & Johnson total return outperformed the DOW average for my 49.2...
Share
Johnson & Johnson
Nurofen maker acquires US baby food and Choco Milk company
The GuardianJulia Kollewe
Reckitt Benckiser, the company behind Nurofen, Dettol and Durex, is moving into baby food with the $16.6bn (£13.2bn) acquisition of US infant formula maker, its biggest deal ever. Mead Johnson Nutrition makes Enfa formula, which it says is the main infant nutrition...
Share
Actelion Pharmaceuticals, Johnson & Johnson
Johnson & Johnson To Acquire Actelion For $30 Billion: Is This A Smart Move?
Seeking AlphaFriedrich Research
Summary Explains why Johnson & Johnson got themselves a bargain in Actelion. Analyzes Actelion using Swiss financial data. Compares Johnson & Johnson to Actelion and shows why adding the later makes Johnson & Johnson a stronger company. Talks about Actelion's main competitor...
Share
Abbott Laboratories, Johnson & Johnson
Medical device market to reach $428.97B by 2020 — 6 details
Becker's Spine ReviewAdam Schrag
The global medical device technology market is expected to grow at a CAGR of 5.5 percent during the 2015 to 2020 forecast period with IVD and orthopedic devices leading the way, according to a Markets and Markets report written about in Whatech....
Share
Actelion Pharmaceuticals, Health Finance
Johnson & Johnson: Betting On Growth
Seeking AlphaActivist Stocks
Summary J&J: Activists need not apply. JNJ gets its mega drug deal. But this could rekindle activist interest. Johnson & Johnson (NYSE:JNJ) has pulled the trigger on buying up Actelion (OTCPK:ALIOY) for $30 billion, an effort to boost its drug discovery capabilities....
Share